X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.
Company profile
Website
CEO
Paula S. Ragan
Employees
Incorporated
Location
Fiscal year end
Former names
X4 Pharmaceuticals, Inc.
SEC CIK
Latest filings (excl ownership)